Antitumor activity of spinasterol isolated from Pueraria roots

Experimental and Molecular Medicine

Volumn 37, Issue 2, 2005, Pages 111-120

  Jeon, Gook Che ^a   Park, Myoung Soon ^a   Yoon, Do Young ^b   Shin, Chul Ho ^c   Sin, Hong Sig ^a   Um, Soo Jong ^a  

^a Sejong University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Breast neoplasms; Estrogen replacement; Phytoestrogens; Pueraria; Receptors, estrogen; Spinasterol; Therapy

Indexed keywords

ALCOHOL; ALPHA SPINASTEROL; CAMPESTEROL; COUMARIN; COUMESTROL; DAIDZEIN; DAIDZIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOID; GENISTEIN; GENISTIN; PHYTOESTROGEN; PLANT EXTRACT; PUERARIA EXTRACT; PUERARIA LOBATA EXTRACT; PUERARIA MIRIFICA EXTRACT; PUERARIN; SITOSTEROL; STEROL; STIGMASTEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN MCF 7; CHINA; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG ISOLATION; GENETIC TRANSFECTION; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY CANCER; PLANT ROOT; PUERARIA; PUERARIA LOBATA; PUERARIA MIRIFICA; RECEPTOR UPREGULATION; THAILAND; THIN LAYER CHROMATOGRAPHY; UTERINE CERVIX CANCER;

ANIMALIA; LOBATA; MINK CELL FOCUS-FORMING VIRUS; PUERARIA; PUERARIA MIRIFICA; PUERARIA MONTANA VAR. LOBATA;

EID: 18744370232     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2005.15     Document Type: Article

References (27)

1. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson JA, Nilsson S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonist/antagonists. Mol Pharmacol 1998;54;105-12
2. Bradbury RB, White DE. 1954 Estrogens and related substances in plants. Vitamins Horm 1954;12;207-33
3. Cain JC. Miroestrol: an oestrogen from the plant Pueraria mirifica. Nature 1960;188;774-7
4. Harada M, Ueno K. Pharmacological studies on pueraria root. I. Fractional extraction of pueraria root and identification of its pharmacological effects. Chem Pharm Bull (Tokyo) 1975;23;1798-805
5. Herath HM, Athukoralage PS, Jamie JF. A new oleanane triterpenoid from Gordonia ceylanica. Nat Prod Lett 2001;15;339-44
6. Kang JH, Chang SY, Yeom DH, Kim SA, Um SJ, Hong KJ. Weakening of the repressive YY-1 site on the thrombospondin-1 promoter via c-Jun/YY-1 interaction. Exp Mol Med 2004;36;300-10
7. Keung WM, Vallee BL. Kudzu root: an ancient Chinese source of modern antidipsotropic agents. Phytochemistry 1998;47;499-506
8. Kim CJ, Um SJ, Kim TY, Kim EJ, Park TC, Kim SJ, Namkoong SE, Park JS. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells. Int J Gynecol Cancer 2000;10;157-64
9. Kuiper GGJM, Gustafsson JA. The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 1997;410;87-90
10. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002;288;334-41
11. Lai XL, Tang B. Recent advances in the experimental study and clinical application of Pueraria Iobata (Willd) Ohwi. Zhongguo Zhong Yao Za Zhi 1989;14;308-11
12. Miyazawa M, Sakano K, Nakamura S, Kosaka H. Antimutagenic activity of isoflavone from Pueraria Iobata. J Agric Food Chem 2001;49;336-41
13. Nilsson S, Kuiper GGJM, Gustafsson J-A. ERβ: A novel estrogen receptor offers the potential for new drug development. Trends Endocrinol Metab 1998;9;387-95
14. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001;81;1535-65
15. Ohshima Y, Okuyama T, Takahashi K, Takizawa T, Shibata S. Isolation and high performance liquid chromatography (HPLC) of isoflavone from the Pueraria Root. Planta Med 1988;54;250-4
16. Osborne CK, Schiff R, Fuqua SA, Shou J. Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res 2001;7(12 Suppl);4338s-42s
17. Pech GG, Brito WF, Mena GJ, Quijano L. Constituents of Acacia cedilloi and Acacia gaumeri. Revised structure and complete NMR assignments of resinone. Z Naturforsch [C] 2002;57;773-6
18. Qicheng F. Some current study and research approaches relating to the use of plants in the traditional Chinese medicine. J Ethnopharmacol 1980;2;57-63
19. Reddel RR, Sutherland RL. Effects of pharmacological concentration and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res 1987;47;5323-29
20. Rodriguez JB, Gros EG, Bertoni MH, Cattaneo P. The sterols of Cucurbita moschata ("calabacita") seed oil. Lipids 1996;31;1205-8
21. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283;485-91
22. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83;2223-35
23. This P, De La Rochefordiere A, Clough K, Fourquet A, Magdelenat H, The Breast Cancer Group of the Institut Curie. Phytoestrogens after breast cancer. Endocr Relat Cancer 2001;8;129-34
24. Um SJ, Kim EJ, Hwang ES, Kim SJ, Namkoong SE, Park JS. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int J Cancer 2000;85;416-23
25. Villasenor IM, Domingo AP. Anticarcinogenicity potential of spinasterol isolated from squash flowers. Teratog Carcinog Mutagen 2000;20;99-105
26. Xu L, Liu J, Min D, Wang S, Zhang Z, Guo D, Zheng K. Chemical constituents of Conyza blinii Levl. Zhongguo Zhong Yao Za Zhi 1998;23;293-5
27. Yang S, Zhong Y, Luo H, Ding X, Zuo C. Studies on chemical constituents of the roots of Gypsophila oldhamiana Miq. Zhongguo Zhong Yao Za Zhi 1999;24;680-1